Conley et al. [21] showed that MAGE-A3 mRNA and protein expression is associated with worse OS in undifferentiated pleomorphic sarcoma/myxofibrosarcoma, which is consistent with our findings, and could make this a clinically relevant target for future investigation. This evidence concerns the gene MAGEA3 and undifferentiated pleomorphic sarcoma.